Barry T. Mori
Finanzdirektor/CFO bei InterX, Inc.
Profil
Barry T.
Mori is currently the Chief Financial Officer & Director at InterX, Inc. Previously, he worked as the Chief Financial Officer & Vice President at Perquest, Inc. Mori holds an MBA from the University of California, Los Angeles and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Barry T. Mori
| Unternehmen | Position | Beginn |
|---|---|---|
InterX, Inc.
 InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Barry T. Mori
| Unternehmen | Position | Ende |
|---|---|---|
Perquest, Inc.
 Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Finanzdirektor/CFO | - |
Ausbildung von Barry T. Mori
| University of California, Los Angeles | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Perquest, Inc.
Perquest, Inc. Miscellaneous Commercial ServicesCommercial Services Perquest, Inc. provides online payroll and employer services. The company was founded by David E. Kahn in 2001 and is headquartered in Dublin, CA. | Commercial Services |
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
